Loading...

Neil Mehta, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address513 Parnassus Ave, MSB
San Francisco CA 94117
Phone415-502-2569
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoM.D.2006 Medicine

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reply to HEP-20-0970. Hepatology. 2020 Jun 24. Mehta N, Yao FY. PMID: 32583439.
      View in: PubMed   Mentions:    Fields:    
    2. Donation after Circulatory Death is Associated with Similar Post-Transplant Survival in All but the Highest Risk Hepatocellular Carcinoma Patients. Liver Transpl. 2020 Jun 12. Silverstein J, Roll G, Dodge JL, Grab JD, Yao FY, Mehta N. PMID: 32531867.
      View in: PubMed   Mentions:    Fields:    
    3. Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation. 2020 Jun; 104(6):1136-1142. Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, Durand F, Ijzermans J, Polak W, Zheng S, Roberts JP, Sapisochin G, Hibi T, Kwan NM, Ghobrial M, Soin A. PMID: 32217938.
      View in: PubMed   Mentions:    Fields:    
    4. Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short-Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change. Liver Transpl. 2020 May; 26(5):662-672. Brondfield MN, Dodge JL, Hirose R, Heimbach J, Yao FY, Mehta N. PMID: 31833634.
      View in: PubMed   Mentions:    Fields:    
    5. Shorter Height Is Associated With Lower Probability of Liver Transplantation in Patients With Hepatocellular Carcinoma. Transplantation. 2020 May; 104(5):988-995. Lee E, Sarkar M, Dodge J, Kohi M, Mehta N. PMID: 31577670.
      View in: PubMed   Mentions:    Fields:    
    6. Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion - a multi-center retrospective cohort study. Transpl Int. 2020 May; 33(5):567-575. Assalino M, Terraz S, Grat M, Lai Q, Vachharajani N, Gringeri E, Bongini MA, Kulik L, Tabrizian P, Agopian V, Mehta N, Brustia R, Vitali GC, Andres A, Berney T, Mazzaferro V, Compagnon P, Majno P, Cillo U, Chapman W, Zieniewicz K, Scatton O, Toso C. PMID: 31994238.
      View in: PubMed   Mentions:    Fields:    
    7. Hepatocellular carcinoma demonstrates heterogeneous growth patterns in a multi-center cohort of patients with cirrhosis. Hepatology. 2020 Feb 04. Rich NE, John BV, Parikh ND, Rowe I, Mehta N, Khatri G, Thomas SM, Anis M, Mendiratta-Lala M, Hernandez C, Odewole M, Sundaram LT, Konjeti VR, Shetty S, Shah T, Zhu H, Yopp AC, Hoshida Y, Yao FY, Marrero JA, Singal AG. PMID: 32017165.
      View in: PubMed   Mentions: 2     Fields:    
    8. Hepatocellular Carcinoma-How to Determine Therapeutic Options. Hepatol Commun. 2020 Mar; 4(3):342-354. Mehta N. PMID: 32140653.
      View in: PubMed   Mentions:
    9. The Impact of Direct Acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.: An International Multicenter Study. Transplantation. 2020 Jan 16. Gorgen A, Galvin Z, Huang AC, Vinaixa C, O'Rourke JM, Francoz C, Hansen BE, Durand F, Elsharkawy AM, Shah T, Berenguer M, Rubin A, Calatayud D, Mehta N, Terrault NA, Lilly LB, Selzner N, Sapisochin G. PMID: 31978002.
      View in: PubMed   Mentions:    Fields:    
    10. Surveillance for HCC after Liver Transplantation: Increased monitoring may yield aggressive treatment options and improved postrecurrence survival. Transplantation. 2020 Jan 13. Lee DD, Sapisochin G, Mehta N, Gorgen A, Musto KR, Hajda H, Yao FY, Hodge DO, Carter RE, Harnois DM. PMID: 31972705.
      View in: PubMed   Mentions:    Fields:    
    11. Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma. Liver Transpl. 2020 Mar; 26(3):349-358. Cullaro G, Rubin JB, Mehta N, Lai JC. PMID: 31610089.
      View in: PubMed   Mentions:    Fields:    
    12. National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time. Hepatology. 2020 Mar; 71(3):943-954. Mehta N, Dodge JL, Grab JD, Yao FY. PMID: 31344273.
      View in: PubMed   Mentions:    Fields:    
    13. REPLY. Hepatology. 2019 10; 70(4):1491-1492. Mehta N, Dodge JL, Yao FY. PMID: 31095762.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance. JAMA Netw Open. 2019 Aug 02; 2(8):e1910326. Gutin L, Yao F, Dodge JL, Grab J, Mehta N. PMID: 31469395.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Using Standardized Checklists Increase the Completion Rate of Critical Actions in an Evacuation from the Operating Room: A Randomized Controlled Simulation Study. Prehosp Disaster Med. 2019 Aug; 34(4):393-400. Acar YA, Mehta N, Rich MA, Yilmaz BK, Careskey M, Generoso J, Fidler R, Hirsch J. PMID: 31389323.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    16. Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2. Singal AG, Rich NE, Mehta N, Branch AD, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Ioannou GN, Huang A, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Kagan S, Gopal P, Wong R, Parikh ND, Murphy CC. PMID: 31374215.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 Apr; 18(4):974-983. Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran SL, Zheng E, Jou JH, Hanje J, Pillai A, Hernaez R, Wong R, Scaglione S, Samant H, Kapuria D, Chandna S, Rosenblatt R, Ajmera V, Frenette CT, Satapathy SK, Mantry P, Jalal P, John BV, Fix OK, Leise M, Lindenmeyer CC, Flores A, Patel N, Jiang ZG, Latt N, Dhanasekaran R, Odewole M, Kagan S, Marrero JA, Singal AG. PMID: 31357028.
      View in: PubMed   Mentions:    Fields:    
    18. Are There Upper Limits in Tumor Burden for Down-Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All-Comers Protocol. Hepatology. 2019 10; 70(4):1185-1196. Sinha J, Mehta N, Dodge JL, Poltavskiy E, Roberts J, Yao F. PMID: 30779440.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation. Am J Transplant. 2019 08; 19(8):2210-2218. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. PMID: 30861298.
      View in: PubMed   Mentions:    Fields:    
    20. PS-206-Patterns and predictors of alcohol use after early liver transplant for alcoholic hepatitis. Journal of Hepatology. 2019 Apr 1; 70(1):e137. Brian Lee, Mary Rinella, Gene Im, John Rice, Oren Fix, George Therapondos, Hyosun Han, David Victor, Ethan Weinberg, Cristine Hsu, Michael Voigt, Haripriya Maddur, Sheila Eswaran, David Foley, R. Mark Ghobrial, Lisanne Dinges, Jennifer Dodge, Neil Mehta, Michael R. Lucey, Norah Terrault. .
      View in: Publisher Site   Mentions:
    21. A Curriculum for Diagnostic Reasoning: JGIM's Exercises in Clinical Reasoning. J Gen Intern Med. 2019 03; 34(3):344-345. Subramanian A, Connor DM, Berger G, Lessing JN, Mehta N, Manesh R, Kohlwes J. PMID: 30334181.
      View in: PubMed   Mentions:    Fields:    
    22. What Are the Optimal Liver Transplantation Criteria for Hepatocellular Carcinoma? Clin Liver Dis (Hoboken). 2019 Jan; 13(1):20-25. Mehta N, Yao FY. PMID: 31168361.
      View in: PubMed   Mentions:
    23. Alpha-Fetoprotein Decrease from > 1,000 to < 500 ng/mL in Patients with Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. Hepatology. 2019 03; 69(3):1193-1205. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. PMID: 30548884.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    24. The mRECIST Classification Provides Insight into Tumor Biology for Patients With Hepatocellular Carcinoma Awaiting Liver Transplantation. Liver Transpl. 2019 02; 25(2):228-241. Lee DD, Samoylova M, Mehta N, Musto KR, Roberts JP, Yao FY, Harnois DM. PMID: 30198150.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria. Liver Transpl. 2019 02; 25(2):207-216. Sherman CB, Behr S, Dodge JL, Roberts JP, Yao FY, Mehta N. PMID: 30246323.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study. Gastroenterology. 2019 05; 156(6):1683-1692.e1. Singal AG, Rich NE, Mehta N, Branch A, Pillai A, Hoteit M, Volk M, Odewole M, Scaglione S, Guy J, Said A, Feld JJ, John BV, Frenette C, Mantry P, Rangnekar AS, Oloruntoba O, Leise M, Jou JH, Bhamidimarri KR, Kulik L, Tran T, Samant H, Dhanasekaran R, Duarte-Rojo A, Salgia R, Eswaran S, Jalal P, Flores A, Satapathy SK, Wong R, Huang A, Misra S, Schwartz M, Mitrani R, Nakka S, Noureddine W, Ho C, Konjeti VR, Dao A, Nelson K, Delarosa K, Rahim U, Mavuram M, Xie JJ, Murphy CC, Parikh ND. PMID: 30660729.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Screening for Hepatocellular Carcinoma to Improve Cancer-Related Mortality: Looking Behind When We Should Be Looking Ahead. Gastroenterology. 2019 03; 156(4):1215-1217. Mehta N, Monto A, Yao FY. PMID: 30543796.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    28. Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation. HPB (Oxford). 2019 06; 21(6):731-738. Goldaracena N, Mehta N, Scalera I, Sposito C, Atenafu EG, Yao FY, Muiesan P, Mazzaferro V, Sapisochin G. PMID: 30391218.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation. Liver Transpl. 2018 10; 24(10):1346-1356. Mehta N, Dodge JL, Hirose R, Roberts JP, Yao FY. PMID: 30067889.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma. Liver Transpl. 2018 09; 24(9):1171-1177. Samoylova ML, Mehta N, Roberts JP, Yao FY. PMID: 29781162.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. A Point-based Histologic Scoring System for Hepatocellular Carcinoma Can Stratify Risk of Posttransplant Tumor Recurrence. Am J Surg Pathol. 2018 07; 42(7):855-865. Roberts DE, Kakar S, Mehta N, Gill RM. PMID: 29649017.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Cardiac MRI T2* in Liver Transplant Candidates: Application and Performance of a Novel Imaging Technique to Identify Patients at Risk for Poor Posttransplant Cardiac Outcomes. Transplant Direct. 2018 Jul; 4(7):e363. Lewin SM, Kallianos K, Nevah MI, Zhao S, Fix OK, Brooks GC, De Marco T, Qasim AN, Ordovas KG, Mehta N. PMID: 30046653.
      View in: PubMed   Mentions:
    33. Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout. Hepatology. 2018 08; 68(2):449-461. Huang AC, Mehta N, Dodge JL, Yao FY, Terrault NA. PMID: 29476694.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    34. Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation. 2018 05; 102(5):816-822. Giard JM, Mehta N, Dodge JL, Roberts JP, Yao FY. PMID: 29505494.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    35. Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis. Gastroenterology. 2018 08; 155(2):422-430.e1. Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, Im GY, Therapondos G, Han H, Victor DW, Fix OK, Dinges L, Dronamraju D, Hsu C, Voigt MD, Rinella ME, Maddur H, Eswaran S, Hause J, Foley D, Ghobrial RM, Dodge JL, Li Z, Terrault NA. PMID: 29655837.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    36. SAT-448 Higher early post-liver transplant mortality in recipients with severe alcoholic hepatitis versus alcoholic cirrhosis. Journal of Hepatology. 2018 Apr 1; 68:s808. B. Lee, G. Im, J. Dodge, M. Voigt, J. Rice, M.R. Lucey, D. Foley, L. Platt, A. Gurakar, N. Mehta, G. Therapondos, H. Han, D. Victor, O. Fix, L. Dinges, D. Dronamraju, C. Hsu, M. Rinella, H. Maddur, S. Eswaran, J. Hause, R.M. Ghobrial, Z. Li, N. Terrault. .
      View in: Publisher Site   Mentions:
    37. Abstract No. 522 Outcomes of TACE for hepatocellular carcinoma in patients with HIV infection. Journal of Vascular and Interventional Radiology. 2018 Apr 1; 29(4):s220. E. Phillips, R. Kohlbrenner, A. True-Yasaki, N. Fidelman, A. Taylor, E. Lehrman, M. Kohi, K. Kolli, R. Kerlan, N. Mehta. .
      View in: Publisher Site   Mentions:
    38. Abstract No. 525 Liver transplantation rates for hepatocellular carcinoma: is there a sex-related difference?. Journal of Vascular and Interventional Radiology. 2018 Apr 1; 29(4):s221. M. Kohi, M. Sarka, J. Dodge, J. Roberts, N. Terrault, N. Mehta. .
      View in: Publisher Site   Mentions:
    39. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma. Transplantation. 2018 04; 102(4):640-647. Sadler EM, Mehta N, Bhat M, Ghanekar A, Greig PD, Grant DR, Yao F, Sapisochin G. PMID: 29319620.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Living donor liver transplantation for hepatocellular carcinoma: To expand (beyond Milan) or downstage (to Milan)? Liver Transpl. 2018 03; 24(3):327-329. Mehta N, Yao FY. PMID: 29351366.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. Hilar cholangiocarcinoma associated with immunoglobulin G4-positive plasma cells and elevated serum immunoglobulin G4 levels. Hepatol Commun. 2018 04; 2(4):349-353. Azeem N, Ajmera V, Hameed B, Mehta N. PMID: 29619414.
      View in: PubMed   Mentions:
    42. Interventions to improve the mechanical ventilation fidelity of the Laerdal SimMan® 3G simulation mannequin. Can J Anaesth. 2018 05; 65(5):600-602. Mehta NJ, Latoures R, Stechert MM, Fidler RL, Hirsch J. PMID: 29243162.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    43. Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database. Am J Transplant. 2018 05; 18(5):1206-1213. Mehta N, Dodge JL, Roberts JP, Yao FY. PMID: 29068145.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Con: Treating hepatitis C virus With direct-acting antivirals: Fear not the perceived threat of hepatocellular carcinoma. Liver Transpl. 2017 12; 23(12):1596-1600. Mehta N, Yao FY. PMID: 29024442.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    45. Excellent Outcomes of Liver Transplantation Following Down-Staging of Hepatocellular Carcinoma to Within Milan Criteria: A Multicenter Study. Clin Gastroenterol Hepatol. 2018 06; 16(6):955-964. Mehta N, Guy J, Frenette CT, Dodge JL, Osorio RW, Minteer WB, Roberts JP, Yao FY. PMID: 29175528.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    46. Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form. Clin Transplant. 2017 Nov; 31(11). Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. PMID: 28881064.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot". Transplantation. 2017 09; 101(9):2071-2078. Mehta N, Heimbach J, Lee D, Dodge JL, Harnois D, Burns J, Sanchez W, Roberts JP, Yao FY. PMID: 28353492.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    48. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 08; 23(8):1015-1022. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. PMID: 28340509.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    49. Acute liver injury in a Glatopa-treated patient with MS. Neurol Neuroimmunol Neuroinflamm. 2017 Jul; 4(4):e368. Sabatino JJ, Mehta NJ, Kakar S, Zamvil SS, Cree BAC. PMID: 28626784.
      View in: PubMed   Mentions:    Fields:    
    50. Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2017 05; 101(5):1001-1008. Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC. PMID: 27926593.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    51. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant. JAMA Oncol. 2017 Apr 01; 3(4):493-500. Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY. PMID: 27838698.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    52. Screening for hepatocellular carcinoma: What is missing? Hepatol Commun. 2017 02; 1(1):18-22. Mehta NJ, Celik AD, Peters MG. PMID: 29404430.
      View in: PubMed   Mentions:
    53. Transarterial Radioembolization for Hepatocellular Carcinoma: Who, When… and Y(90)? Gastroenterology. 2016 12; 151(6):1062-1065. Mehta N, Yao FY. PMID: 27983951.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology. 2016 10; 64(4):1178-88. Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, Vibert E, Cherqui D, Grant DR, Hernandez-Alejandro R, Dale CH, Cucchetti A, Pinna A, Hwang S, Lee SG, Agopian VG, Busuttil RW, Rizvi S, Heimbach JK, Montenovo M, Reyes J, Cesaretti M, Soubrane O, Reichman T, Seal J, Kim PT, Klintmalm G, Sposito C, Mazzaferro V, Dutkowski P, Clavien PA, Toso C, Majno P, Kneteman N, Saunders C, Bruix J. PMID: 27481548.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    55. Reply. Liver Transpl. 2016 08; 22(8):1164-5. Mehta N, Yao FY. PMID: 27097078.
      View in: PubMed   Mentions:    Fields:    
    56.  Increased hepatocellular carcinoma recurrence in women compared to men with high alpha fetoprotein at liver transplant. Ann Hepatol. 2016 Jul-Aug; 15(4):545-9. Sarkar M, Dodge JL, Roberts JP, Terrault N, Yao F, Mehta N. PMID: 27236153.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    57. Lack of benefits of mammalian target of rapamycin inhibitor in patients transplanted for hepatocellular carcinoma: Is this the end of the story? Liver Transpl. 2016 05; 22(5):582-4. Mehta N, Roberts JP, Yao FY. PMID: 26951991.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    58. Immigrant status and cardiovascular risk over time: results from the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol. 2016 06; 26(6):429-435.e1. Lê-Scherban F, Albrecht SS, Bertoni A, Kandula N, Mehta N, Diez Roux AV. PMID: 27221804.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    59. HCC recurrence following liver tranplantation should be aggresively treated to increase patient survival. Hepato Pancreato Biliary. 2016 Apr 1; 18:e197. G. Sapisochin, N. Mehta, I. Scalera, C. Sposito, F.Y. Yao, P. Muiesan, V. Mazzaferro, D.R. Grant. .
      View in: Publisher Site   Mentions:
    60. “Very early” intrahepatic cholangiocarcinoma may become an acceptable indication for liver transplantation. A multicenter validation study. Hepato Pancreato Biliary. 2016 Apr 1; 18:e46-e47. G. Sapisochin, M. Facciuto, N. Mehta, E. Vibert, R. Hernandez-Alejandro, A.D. Pinna, S. Hwang, V.G. Agopian, G. Gores, J. Reyes, O. Soubrane, T. Reichman, P. Kim, C. Sposito, P.A. Clavien, C. Toso, N. Kneteman, J. Bruix. .
      View in: Publisher Site   Mentions:
    61. Hepatocellular cancer as indication for liver transplantation: pushing beyond Milan. Curr Opin Organ Transplant. 2016 Apr; 21(2):91-8. Mehta N, Yao FY. PMID: 26807513.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Nucleos(t)ide analogs reduce the risk of hepatitis B-associated hepatocellular carcinoma: A can't miss proposition? Hepatology. 2016 May; 63(5):1415-7. Mehta N, Yao FY. PMID: 26679367.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver Transpl. 2016 Feb; 22(2):178-87. Mehta N, Sarkar M, Dodge JL, Fidelman N, Roberts JP, Yao FY. PMID: 26479422.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    64. Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy? Gastroenterology. 2016 Feb; 150(2):533-4. Mehta N, Heimbach J, Hirose R, Roberts JP, Yao FY. PMID: 26718172.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    65. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria. Hepatology. 2015 Jun; 61(6):1968-77. Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP. PMID: 25689978.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    66. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm. Clin Transplant. 2015 Jan; 29(1):52-9. Samoylova ML, Dodge JL, Mehta N, Yao FY, Roberts JP. PMID: 25366656.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    67. Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization. Liver Transpl. 2014 Oct; 20(10):1221-8. Goel A, Mehta N, Guy J, Fidelman N, Yao F, Roberts J, Terrault N. PMID: 25045002.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    68. Response to letter to the editors. Liver Transpl. 2014 Oct; 20(10):1285. Yao FY, Hameed B, Mehta N, Roberts JP. PMID: 25155484.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria. Liver Transpl. 2014 Aug; 20(8):945-51. Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY. PMID: 24797281.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    70. Should Hepatocellular Carcinoma Patients With Multiple Tumors <2cm Be Transplanted?. Transplantation Journal. 2014 Jul 1; 98:698. M. Samoylova, J. Dodge, F. Yao, N. Mehta, J. Roberts. .
      View in: Publisher Site   Mentions:
    71. Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list. Liver Transpl. 2014 May; 20(5):627-8. Mehta N, Dodge JL, Roberts JP, Hirose R, Yao FY. PMID: 24493311.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    72. BMJ endgames: a new web-based BMJ/JGIM collaboration. J Gen Intern Med. 2014 Mar; 29(3):423-4. Srinivasan M, Mehta N. PMID: 24395105.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    73. Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl. 2013 Dec; 19(12):1343-53. Mehta N, Dodge JL, Goel A, Roberts JP, Hirose R, Yao FY. PMID: 24285611.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    74. Adult-Onset Fatal Neurohepatopathy in a Woman Caused by MPV17 Mutation. JIMD Rep. 2014; 13:37-41. Mendelsohn BA, Mehta N, Hameed B, Pekmezci M, Packman S, Ralph J. PMID: 24190800.
      View in: PubMed   Mentions:
    75. Moving past "One size (and number) fits all" in the selection of candidates with hepatocellular carcinoma for liver transplantation. Liver Transpl. 2013 Oct; 19(10):1055-8. Mehta N, Yao FY. PMID: 23959652.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    76. Reply: To PMID 23333661. Clin Gastroenterol Hepatol. 2013 Dec; 11(12):1674. Yao F, Mehta N. PMID: 24035772.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Immunosuppression: Conventions and controversies. Clin Liver Dis (Hoboken). 2013 Aug; 2(4):188-191. Mehta N, Hirose R. PMID: 30992859.
      View in: PubMed   Mentions:
    78. Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2013 May; 11(5):572-8. Mehta N, Fidelman N, Sarkar M, Yao FY. PMID: 23333661.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    79. 1016 Risk of Hepatic Artery and Biliary Complications in Liver Transplant Recipients Treated With Transarterial Chemoembolization. Gastroenterology. 2012 May 1; 142(5):s-939-s-940. Neil Mehta, Aparna Goel, Karen C. Bagatelos, James L. Buxbaum, Nicholas Fidelman, John P. Roberts, Norah A. Terrault, Francis Yao, James W. Ostroff. .
      View in: Publisher Site   Mentions:
    Neil's Networks
    Concepts (159)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (42)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑